APPLICATIONS PUBLISHED 10 SEPTEMBER 2003
Published: 1-Feb-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Nanoparticles with an improved release profile and method for the production thereof
Merckle 1341522*
Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
Altana Pharma 1341523*
Novel process
SmithKline Beecham 1341524*
Pharmaceutical compsns for the oral delivery of pharmacologically active agents
Novartis 1341526*
Pharmaceutical preparation comprising a active dispersed on a matrix
Altana Pharma 1341527*
Rapidly-disintegrating tablet comprising an acid-labile active ingredient
Altana Pharma 1341528*
Hydrolytically unstable compsns
F Hoffmann-La Roche 1341529*
Use of a dopamine agonist with a short half-life for treating illnesses that can be treated by dopaminergic means
Schering 1341530*
Lactam compound to inhibit beta-amyloid peptide release or synthesis
Eli Lilly; Elan Pharmaceuticals 1341531*
Use of pyridoxamine for the treatment and inhibition of obesity-related complications
University of South Carolina 1341532*
Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Novartis 1341533*
Compounds having fungicidal activity and processes to make and use same
Dow Agrosciences 1341534*
Skin whiteners containing hyroxytetronic acid
Perricone, Nicholas V 1341535*
Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
TAP Pharmaceuticals 1341536*
Pharmaceutically active isoindoline derivatives
Celgene Corp 1341537*
Novel medicament compsn
Boehringer Ingelheim 1341538*
Anti-inflammatory agents
Orion Corp 1341539*
Tyrosine kinase inhibitors
Merck 1341540*
Combination therapy for lowering and controlling intraocular pressure
Alcon Manufacturing 1341541*
Organic compounds
Novartis 1341542*
Methods employing and compsns containing defined oxidised phospholipids for prevention and treatment of atherosclerosis
Vascular Biogenics 1341543*
Blocking the adsorption of germs in birds
de Bettignies-Dutz, Andreas; Guggenbichler, Josef Peter; Jurenitsch, Johann 1341544*
Bone putty and method
Gender, El; Gendler, Eli; Gendler, Simon 1341545*
Kyberdrug as autovaccines with immune-regulating effects
Paradies, Henrish; Rusch, Volker; Zimmerman, Kurt 1341546*
The method of preparation and use of coconut water in mammalian tissue nourishment, growth and healthy maintenance
Sabinsa Corp 1341547*
Methods for identifying treatments for neurotoxicity in Alzheimer's disease caused by b-amyloid peptides
Massachusetts Institute of Technology 1341548*
Combination therapy for estrogen-dependent diseases
Pharmacia & Upjohn 1341549*
Method for treating respiratory distress syndrome
The Nemours Foundation 1341550*
Treatment of posterior capsule opacification
Moorfields Eye Hospital NHS Trust 1341551*
Treatment of immune-mediated diseases by oral administration of plasma fractions
Research Corp Technologies 1341552*
Silenced anti-CD28 antibodies and use thereof
Tso, J Yun; Hinton. Paul; Vasquez, Maximiliano. Temura, Kouichi; Higashi, Yasuyuki; Seki, Nobu; Ueda, Hirotugu 1341553*
Colostrum-based compsn
Fonterra Co-Operative Group 1341554*
Pharmaceutical ozaliplatinum preparation for parenteral administration and method for obtaining same
Debiopharm 1341555*
Drug delivery system
Isis Innovation 134556*
Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
Beth Israel Deaconess Medical Centre 1341557*
A novel system for the evaluation of the activity and/or specificity of a viral component
Institut fuer Virologie Tellrechtsfaehiges Institut an der Veterinaermedizinischen Universitaet Wien 1341558*
Dressings for the treatment of exuding wounds
Johnson & Johnson Medical 1341561*
Distribution layer having improved liquid transfer to a storage layer
Wayerhaeuser 1341562*
Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1341564*
Drug delivery compsns and coated medical devices
Scimed Life Sciences 1341565*
